FDA approves Datroway for HR-positive, HER2-negative breast cancer
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
FiercePharma2h
Novartis' Kisqali off to 'very rapid' launch in early breast cancer, CEO says. Can it keep up the momentum?
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
food-blog.co.za5h
The Power of Pink Campaign empowers Life beyond a Breast Cancer Diagnosis
R4R has been supporting and uplifting underprivileged breast cancer survivors for over 50 years, and they not only focus their efforts on saving lives, but their passion is to create confident futures ...
Endocrinology Advisor14h
Long-Acting, Reversible Contraceptives Linked to Increased Risk of Cancer
Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.
How tech can get more people into clinical trials
Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...
Tough Enough to Wear Pink project returns to Black Hills Stock Show
If you plan on going to the Black Hills Stock Show and Rodeo starting Friday, you may notice a lot of pink thanks to the ...
verywellhealth20h
Navigating Care Through Every Phase of Metastatic Breast Cancer
If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...
AI predicts breast cancer risk years before diagnosis, Norwegian study finds
Norwegian Institute of Public Health says AI use could improve early detection, reduce costs, and better target at-risk ...